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Summary 
Antigen-presenting cells contain a specialized late endocytic compartment, MIIC (major histo- 
compatibility complex [MHC] class II-enriched compartment), that harbors newly synthesized 
MHC class II molecules in transit to the plasma membrane. MIICs have a limiting membrane 
enclosing characteristic internal membrane vesicles. Both the limiting membrane and the inter- 
nal vesicles  contain MHC class II. In this study on B lymphoblastoid cells, we demonstrate by 
immunoelectron miroscopy that the limiting membrane of MIICs  can fuse directly with the 
plasma membrane, resulting in release from the cells of internal MHC class II-containing vesi- 
cles.  These secreted vesicles,  named exosomes, were isolated from the cell culture media by 
differential centrifugation followed by flotation on sucrose density gradients. The overall sur- 
face protein composition of exosomes differed significantly from that of the plasma  membrane. 
Exosome-bound MHC class II was in a compact, peptide-bound conformation. Metabolically 
labeled MHC class II was released into the extracellular medium with relatively slow kinetics, 
10 -  4% in 24 h, indicating that direct fusion of MIICs with the plasma membrane is not the 
major pathway by which MHC class II reaches the plasma membrane. Exosomes derived from 
both human and murine B  lymphocytes induced antigen-specific MHC  class II-restricted T 
cell responses. These data suggest a role for exosomes in antigen presentation in vivo. 
H 
elper T  lymphocytes recognize exogenous antigens 
bound  to MHC  class II molecules, displayed at the 
surface of a variety of APC  such as macrophages, B  lym- 
phocytes, and dendritic cells including Langerhans cells of 
the epidermis. MHC class II molecules are heterodimers of 
two transmembrane proteins, an ot and 13 subunit with mo- 
lecular masses  of 33-35 and 25-30 kD, respectively. After 
biosynthesis, ot and 13 subunits assemble in the endoplasmic 
reticulum with trimers of a nonpolymorphic type II trans- 
membrane polypeptide, the invariant (I) chain (1, 2). After 
transport to the Golgi complex, most of the class II mole- 
cules are targeted to endocytic compartments (3, 4), where 
the I chains are dissociated from the cx/[3 dimers, and de- 
graded, leaving MHC class II molecules ready to bind pep- 
tides derived from endocytosed proteins (5-7). Recent evi- 
dence  has  shown  that  I  chain  dissociation  and  peptide 
binding are facilitated by HLA-DM molecules (8). 
We have recently demonstrated that in human B cells (9) 
and in  dendritic cells,  including Langerhans cells  (10-12) 
and  macrophages  (13),  most  of the  intracellular  class  II 
molecules reside in MHC class II-enriched compartments 
(MIICs). 1 MIICs have lysosomal characteristics: they con- 
tain lysosomal marker molecules (LAMP1, CD63,  [3-hex- 
osaminidase,  and  cathepsin  D),  are positioned late  in  the 
endocytic pathway, and are acidic  (14).  A  further charac- 
terization of MIICs was  accomplished with their purifica- 
tion from murine  macrophages  (15),  human B  cells  (16), 
murine B cells (17,  18), and melanoma cells (19).  Interest- 
ingly, it has recently been shown by immunoelectron mi- 
croscopy that the majority of HLA-DM molecules also re- 
sides  in MIICs  (20).  Together,  these studies  indicate that 
MIICs  are  involved  in  antigen  processing  and  peptide 
binding to class II molecules. However, functionally differ- 
ent subclasses of MIICs may exist (16,  18). In all APC stud- 
ied so far, MIICs and related compartments contain inter- 
nal  membranes  (9,  14,  16).  These  membranes  probably 
originate from inward  vesiculation of the  limiting mem- 
brane of MIICs (21).  Two types of MIICs could be distin- 
guished by morphological criteria: those displaying numer- 
~Abbreviations used in this paper: BSAG, gold particles derivitized  with BSA; 
MIIC, MHC class II-enriched  compartment;  TilL, transferrin  receptor. 
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(10,  16,  22). Whether these two types of MIICs have dif- 
ferential functions in antigen processing and presentation 
remains to be established. 
A major unresolved question in MHC class II trafficking 
concerns the pathway via which intracellular class II mole- 
cules  are  transferred to  the  cell  surface.  In macrophages, 
vesicles emanating from class  II-enriched phagolysosomes 
have been suggested to provide for transport of MHC class 
II molecules to the plasma membrane (13). However, so far 
such vesicles have not been identified in other APC. MIICs 
in B cells and Langerhans cells are spherical structures with- 
out  attached  vesicles  and  tubules  (9-12).  Alternatively, 
MHC  class II molecules may be transported to the plasma 
membrane by trans-Golgl  network-derived vesicles (1, 23). 
So  far no evidence has been presented for either of these 
pathways. 
Using immunoelectron microscopy,  biochemistry,  and 
antigen presentation assays,  we  now show  that  in B  cells 
MIICs  are  exocytic  compartments. After  fusion with  the 
plasma membrane, small vesicles contained within the lu- 
men of the MIICs are released into the extracellular milieu. 
The  externalized vesicles,  termed  exosomes  analogous to 
vesicles released by reticulocytes (24-26), exhibited abun- 
dant MHC  class  II molecules at their surface, and specifi- 
cally presented antigenic peptides to T  cells. Possible roles 
ofexosomes in vivo are discussed. 
Materials and Methods 
Cell Lines and Antibodies.  The EBV-transformed  human B cell 
lines RN  (HLA-DR15  +)  and JY  (HLA-DR15-) were cultured 
in RPMI medium (Gibco Laboratories,  Paisley, Scotland) supple- 
mented with 10% FCS (Hyclone Laboratories,  Inc., Logan, UT) 
and  100  IU penicillin. The T  cell  clone 2F10  recognizing the 
peptide 418-427 from the HSP65  antigen of Mycobacterium  leprae 
in the context of HLA-DR15 was generated as described  (27, 28) 
and cultured in IMDM (Gibco Laboratories) supplemented with 
10% heat-inactivated pooled human serum. The murine B  cell 
line TA3 (H-2  k,d) (29) and the ribonuclease (90-105)-l-E~-spe- 
cific  T  cell hybridoma WA.23 (30) were maintained in DMEM 
with  10%  FCS.  The  antibodies used in this  study were  rabbit 
anti-HLA DR (3, 9), mouse monoclonal anti-DR DA6.231  (31), 
mouse  monoclonal anti-DR  Tfi-36  (32); mouse  monoclonal 
anti-HLA DR.  B.8.11.2,  and mouse monoclonal anti-HLA-DP 
B7.21  (gift of Dr. A.  Mulder, Department of Immunohematol- 
ogy and Blood Bank, University Hospital,  Leiden,  The Nether- 
lands); mouse mAb directed against the lysosomal protein CD63 
(33), rabbit anti-human LAMP1  (34), and  rabbit anti-human 
transferrin  receptor (TFR.) (gift of Dr. Alan Schwartz;  Washing- 
ton University, St. Louis, MO). 
Isolation and Puri~qcation qf Exosomes.  RN  cells  were  washed 
by centrifugation and recultured in fresh medium for  2 d.  Cell 
culture media (35  nil)  containing 2-5  X  10  v cells were  centri- 
fuged for 10 mm at 300g to remove the cells. After a second cen- 
trifugation at 300 g, the medium was centrifuged for  10 rain at 
1,200 g (2 ￿  30 nfin at 10,000 g, 60 rain at 70,000 g, and 60 min 
at  100,000 g sequentially,  using a rotor (SW27; Beckman Instru- 
ments, Inc., Fullerton, CA). The pellets were solubilized in non- 
reducing SDS sample buffer at room temperature for analysis by 
SDS-PAGE and Western blotting as described  previously using 
12SI-protein A (35). When indicated, aliquots of the samples were 
incubated at  100~  in the presence  of [$-ME. For electron nil- 
croscopy,  the  70,000-g  pellet  was  resuspended  in  100  pA  of 
RPMI  medium.  For  further  purification  of  exosomes,  the 
70,000-g pellet was resuspended in 5 nil of 2.5 M sucrose, 20 mM 
Hepes/NaOH, pH 7.2. A linear sucrose gradient (2-0.25 M su- 
crose, 20 mM Hepes/NaOH, pH 7.2) was layered on top of the 
exosome  suspension in  a  tube  (SW27;  Beckman  Instruments, 
Inc.),  and the  sample  was  centrifugated at  100,000 g  for  15  h. 
Gradient fractions (18 ￿  2 ml) were collected from the bottom of 
the tube, diluted with 3 ml PBS, and ultracentrifuged for  1 h at 
200,000 g using a rotor (SW50; Beckman Instruments, Inc.). The 
pellets were  solubilized  in SDS  sample  buffer  lacking [3-ME at 
room temperature  and analyzed by SDS-PAGE and Western blot- 
ting. Protein concentrations were determined using the BCA as- 
say from Pierce  Chemical Co.  (Rockford,  IL). Quantitation of 
MHC class II detected by Western blotting was realized using a 
Phospholmager (Molecular Dynamics, Sunnyvale, CA). 
Biotinylation.  10  s  RN  cells were  washed  three  times  with 
PBS at 0~  by centrifugation and incubated for 30 min at 0~  in 
the  presence  of 1  mg/ml Sulfo-NHS-biotin (Pierce  Chemical 
Co.). Nonreacted biotin was then quenched for 30 min with 15 
mlVl NH4C1. The cells were washed with PBS at 0~  and lysed in 
1 ml lysis buffer (50 mM Tris-HCl, pH 7.5, 0.5% NP-40, 5 mM 
MgCI~,  0.5  p,g/ml  leupeptin, 0.7  p~g/ml pepstatin,  20  I~g/ml 
aprotinin, 0.1 mM PMSF). Nuclei were removed from the lysate 
by centrifugation. Exosomes  secreted  by 2  ￿  l0  s cells were iso- 
lated  by differential  centrifugation followed by flotation on su- 
crose gradients as described above. Exosome pellets obtained from 
pooled sucrose  gradient fractions  were resuspended  in PBS and 
biotinylated as described  above for  cells. Biotinylated exosomes 
were then pelleted through 0.3 M sucrose, 20 mM Hepes/NaOH, 
pH 7.2, and solubilized in lysis buffer. MHC class II was immu- 
noprecipitated from  samples  containing lysed  biotinylated cells 
and exosomes  using the anti-class  II mAbs DA6.231  or Tii-36. 
The mAbs were adsorbed  from hybridoma culture supernatants 
using protein A-Sepharose beads (Pharmacia Biotech  Inc., Pisca- 
taway, NJ). Antibody-coated  beads were washed with inununomix 
(50 mM Tris-HC1, pH 7.5, 0.5% NP-40, 5 mM EDTA, 150 mM 
NaC1,  0.1  mM PMSF)  and added  to  the lysates that  had been 
precleared  with protein A-Sepharose. After a 16-h incubation at 
4~  the beads were washed  extensively  with immunomix, lm- 
munoprecipitated MHC class II and samples of the total cell and 
exosome lysates were eluted from the beads in SDS sample buffer 
at reducing conditions at 95~  and analyzed by SDS-PAGE and 
Western blotting. After the transfer to Immobilon-P membranes 
(Millipore Corp., Milford, MA), the membranes were blocked in 
PBS containing  0.1% gelatin, 0.05 Triton X-100, and 0.01% anti- 
foam (Sigma Chemical Co., St. Louis, MO). Biotinylated proteins 
were labeled using USl-streptavidin (0.1 p~g/nil, 2 ￿  l0  ~ cpm/p~g) 
and detected using a Phospholmager (Molecular Dynamics). 
Afetabolic Labeling.  Cells were washed three times with MEM 
lacking methionine and cysteine and preincubated for 45 rain at 
37~  in a 5% CO, atmosphere.  Cells were then pulsed for 45 rain 
with  50  Mbq/ml  [3SS]methionine  (Tran-S-label; ICN,  Irvine, 
CA) and chased  for  different  periods  of time in RPMI supple- 
mented with  10% FCS,  1 mM methionine, and 1 mM cysteine 
(5 ￿  10  v cells/time point). Afi:er pulse-chase labeling,  the  cells 
were pelleted by centrifugation ~br 10 min at 300g. The superna- 
tants  were  collected  and centrifuged for 5 rain at  10,000 g fol- 
lowed by 30 rain at 200,000 g in a rotor (model SW60; Beckman 
Instruments, Inc.).  Cells and the 200,000-g  pellets were lysed in 
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cell lysates by centrifugation for 5 min at 10,000 g. MHC class II 
was immunoprecipitated as described above. Till was immuno- 
precipitated as described previously (35). Precipitated MHC class 
II was eluted from the beads in SDS sample buffer at nonreducing 
conditions at room temperature. Precipitated Tfl~ was eluted from 
the beads in SDS-sample buffer at reducing conditions at 95~ 
Immunoprecipitates were analyzed by SDS-PAGE and fluorogra- 
phy. MHC class II was quantified using a Phospholmager. 
hnmunoelectron Microscopy.  The ILN B cell line and the T2-DR.3 
cell line were pulse incubated with  5-nm  gold particles deriv- 
itized with BSA (BSAG ODs20 =  5 in RPMI medium lacking se- 
rum)  for  10 rain at 37~  The cells were washed extensively at 
4~  with RPMI medium by centrifugation and chase incubated 
at 37~  for 10, 20, 50 or 80 rain in the absence of BSAG. The 
cells were fixed in a mixture of 2% paraformaldehyde-0.2% glu- 
taraldehyde in 0.1 M phosphate buffer, pH 7.4, and processed for 
ultracryomicrotomy and immunolabeling (36). To improve ultra- 
structure and visualization of membranes, the ultrathin cryosec- 
tions were collected as described by Liou and Slot (37).  For elec- 
tron microscopy of the isolated exosomes, droplets of RPMI with 
suspended membranes from 70,000-g pellets (see above) were put 
on  Formvar-carbon-coated electron  microscopy grids,  fixed as 
above, immunolabeled, and stained using the method described for 
ultrathin cryosecrions. 
Antigen Presentation Assays.  The EBV-B cell lines RN (HLA- 
DR 15 +) andJY (HLA-DR 15-) were incubated in the presence 
or absence of purified HSP 65 protein from M. leprae (50 p,g/ml) 
(38) for 4 h in 10 ml serum-free RPMI at 2 ￿  106 cells/ml. Then 
30 ml of RPMI supplemented with 10% FCS was added, and the 
cells were incubated for 20 h at 37~  The cells were then washed 
to remove free antigen and incubated further for 24 h in RPMI/ 
10% FCS medium at 37~  Exosomes were prepared by differen- 
tial centrifugation as described above. The efficiency of HSP 65 
antigen presentation was measured by culturing 10,000 cells of the 
T  cell clone 2F10 with irradiated (6,000  rad) EBV cells. As indi- 
cated in the legend to Fig. 6, increasing numbers of cells or dilu- 
tions of exosome preparations were used. The highest concentra- 
tion of exosomes corresponded to material that was secreted by 
1.6 ￿  10  ~ cells in 24 h. B cells or exosomes resuspended in 100 ~1 
IMDM/10%  pooled  human  serum  were  added  to  the  T  cell 
clone (50  ~1 IMDM/10% pooled human serum per well) in 96- 
well flat-bottom microtiter plates (Costar Corp., Badhoevedorp, 
The Netherlands) for 4 d at 37~  5% CO2 in humidified air. An- 
tibodies to HLA class II molecules were added at 10 pMwell in a 
final  concentration  of 10  gzg/ml.  When  indicated,  5  ~g/ml  of 
HLA-DR15-restricted epitope of HSP65  (peptide 418-427)  was 
added  to  the  exosomes.  16  h  before  termination,  0.5  gtCi  of 
[3H]thymidine was added to the wells. The cells were then har- 
vested on glass fiber filters using an automatic cell harvester, and 
the [~H]thymidine incorporation into cell DNA was determined 
by liquid scintillation counting. The  results  are expressed as the 
mean of triplicate measurements.  Exosomes were prepared simi- 
larly from  TA3  cells and  incubated together with  ribonuclease 
(90-105) peptide and WA.23 T  hybridoma cells. After 24 h, su- 
pernatants  were  harvested,  and  the  level  of IL-2  secretion by 
WA.23 cells was determined by CTI_ line bioassay (39). 
Results 
MIICs Can Fuse with the Plasma Membrane.  MIICs con- 
taining abundant MHC  class II molecules are a general fea- 
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ture  of human  and murine B  lymphoblastoid cell lines (3, 
9,  16,  22).  In this study we analyzed immunogold-labeled 
ultrathin cryosections of the human B  cell line RN  by im- 
munoelectron  microscopy and  found  typical MIICs  with 
internal  membranes  abundantly labeled for MHC  class II 
(Fig. 1). Both multivesicular and multilaminar MIICs were 
present. 
The RN  cells displayed many exocytic profiles suggest- 
ing  fusion  of the  limiting membrane  of MIICs  with  the 
plasma membrane.  These profiles contained vesicles remi- 
niscent of those present in the  multivesicular MIICs  (Fig. 
2). Membrane sheets were not found in the fusion profiles, 
indicating that  predominandy  multivesicular MIICs  fused 
with  the  plasma  membrane.  We  named  the  externahzed 
MIIC-derived vesicles exosomes analogous to vesicles that 
are released by reticulocytes as a  consequence  of fusion of 
multivesicular bodies with the plasma membrane  (25,  26). 
Both exosomes and the limiting membranes of the exocytic 
profiles were immunolabeled for MHC  class II (Fig. 2) and 
for  the  lysosomal membrane  proteins  LAMP1  (Fig.  2  B) 
and CD63  (not shown). 
To  further demonstrate that  the  contents  of MIICs can 
be exocytosed, we tested whether previously endocytosed 
BSAG particles were reextemalized and could be found in 
exocytic  profiles.  R.N  cells  were  allowed  to  internalize 
BSAG particles for  10 rain at 37~  washed extensively at 
4~  to remove extracellular BSAG, and chased in the ab- 
sence of BSAG for varying periods of time at 37~  BSAG 
was detected in MIICs after 20 rain of chase (Fig. 1),  con- 
sistent  with  previous  observations  on  dendritic  cells  (10- 
12), theJY B  cell line (9), and other B  cells (16, 22). MIICs 
containing internal vesicles (early MIICs) were reached by 
the BSAG before those accommodating membrane  sheets 
(late MIICs)  (Fig.  1).  BSAG  began  to  appear in  exocytic 
profiles after 20  rain of chase  (Fig. 2 A) and was abundant 
after a 50-rain chase (Fig. 2 B). The observation that BSAG 
was not associated with the plasma membrane after 10 min 
of chase indicated that BSAG recovered in exocytic profiles 
after prolonged chase  times indeed resulted from  reexter- 
nalization. 
Isolation  of Exosomes.  Exosomes were  isolated from  the 
culture  media  of RN  cells  by  differential  centrifugation 
(25).  Pelleted membranes were analyzed by Western blot- 
ting. The majority of MHC  class II-containing membranes 
sedimented at 70,000 g  (Fig. 3 A, lane 6).  To test whether 
secreted MHC  class II molecules were  membrane  bound, 
membranes from the 70,000-g pellets were floated into lin- 
ear sucrose  gradients.  Western  blot  anlaysis  of nonboiled 
and  nonreduced  gradient  fractions  showed  that  compact, 
peptide-bound MHC  class II molecules floated to an equi- 
librium density of I. 13  g/ml,  confirming their association 
with membrane vesicles (Fig. 3  B). Next, membranes from 
the 70,000-g pellet were analyzed morphologically. As can 
be seen in Fig. 3  C, the 70,000-g pellet was composed of a 
homogeneous  population of vesicles of 60--80  nm that la- 
beled for MHC  class II. The vesicles were morphologically 
similar to  those  found  in  sections  of MIICs  (Fig.  1)  and 
exocytic profiles  (Fig.  2).  We  conclude  that  the  secreted Figure  1.  KN  B  cells contain typical 
MIICs. Ultrathin cryosection of an RN 
cell immunolabeled for MHC class II with 
10-nm gold particles as indicated in the 
figure. Cells had internalized 5 nm BSAG 
(BSAG  ~) for 10 min and were chased in 
the absence of BSAG for 20 rain before 
fixation. MHC class II molecules are lo- 
calized in multivesicular and multilaminar 
MIICs. Two types of MIICs containing 
either  vesicles or  membrane  sheets are 
shown. Note that after 30 rain of  internal- 
ization, BSAG is present only in multive- 
sicnlar MIICs (arrows). N, nucleus; M, mi- 
tochondrion. Bar, 0.1 ~m. 
MHC class II molecules were complexed with peptides and 
associated with membrane vesicles. 
Exosome Membranes Are Distinct  horn the Plasma Membrane. 
To  investigate  the  possibility that the  MHC  class  II-con- 
taining vesicles that sedimented at 70,000 g  represent  shed 
plasma membrane fragments,  the presence  of the TfK was 
monitored  by  Western  blotting.  Tfl~s  are  absent  from 
MIICs  (9)  and  from  class  II-enriched  cell  fractions  in  B 
cells  (16).  In most  cell  types,  including B  cells,  Tfl~s  are 
predominantly  present  at  the  plasma  membrane  and  in 
early endosomes.  Tfl~s have been localized in the limiting 
membrane  of multivesicular bodies in most cell types, but 
not in their internal vesicles (40). Fig. 4 A  shows that Tfl~s 
were  only detectable  in  the  cell lysate  (lane  3)  but not in 
the 70,000-g pellet  (lane  4).  The significant enrichment  of 
MHC  class  II over TftL in  the  70,000-g pellet  compared 
with the cell lysate (compare lanes  1 and 2 with lanes 3 and 
4, respectively) suggests that little if any shed plasma mem- 
brane  contaminated  the  exosome  preparation.  To  further 
analyze  differences  in  protein  composition  of the  plasma 
membrane  and  exosomes,  plasma  membrane  proteins  and 
exosomal  membrane  proteins  were  biotinylated.  Probing 
Western  blots  with  125I-streptavidin  revealed  at  least  four 
proteins that are highly enriched in plasma membranes and 
four proteins that are highly enriched in exosomes (Fig.  4 
B).  MHC  class  II was identified  among the  enriched bio- 
tinylated proteins  in plasma membrane  (lanes  3-5)  and in 
exosomes (lanes  6-8) by immunoprecipitation.  The differ- 
ential membrane  protein  composition  of the  plasma  mem- 
brane  and exosomes again  strongly indicates  that  exosomes 
did not derive from shed plasma membrane. 
Release of Newly Synthesized Class II Molecules.  To  deter- 
mine  the  kinetics  and the  extent  to  which  newly synthe- 
sized MHC class II molecules are released into the medium, 
RN  cells were metabolically pulse labeled with  [3SS]methio- 
nine for 45 min and chased for different periods of time as 
indicated  in Fig.  5.  Cells  and exosomes were  collected by 
centrifugation, lysed, and MHC class II was immunoprecipi- 
tated. After pulse labeling, the majority of 3SS-MHC class II 
in the cells was immunoprecipitated as SDS-unstable c~/[3-I 
chain complexes (Fig. 5 A). These complexes were converted 
to SDS-stable, a/[3-peptide complexes N3 h  after synthesis 
(not shown), consistent with the kinetics reported for other 
human B  cell lines  (3,  41).  After 6  h  of chase,  3SS-MHC 
class  II appeared in the  compact configuration.  Only very 
little  3SS-MHC class  II was detected  in the  exosome frac- 
tion at this time. Increasing amounts of35S-compact MHC 
class II were recovered from the exosomes after 12 and 24 h 
of chase. After 24 h  of chase,  10  +  4%  (n  =  5 from three 
independent  experiments)  of the  total  newly  synthesized 
MHC  class  II was recovered from exosomes. As a control, 
newly  synthesized  3SS-Tt~  was  immunoprecipitated  and 
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membrane. RN B cells were allowed to inter- 
nalize 5 nm BSAG particles for  10 min and 
chased for 20 min (A) or 50 rain  (/3) in the 
absence of BSAG. (A) Ultrathirt cryosections 
immunogold  labeled for  MHC  class II and 
LAMP1 as indicated in the figure. The fusion 
profile is defined by the presence of external- 
ized BSAG that had previously been endocy- 
tosed. In addition to BSAG, the exocytic pro- 
file  contains  MHC  class II-labeled vesicles 
(exosomes). (B)  Exocytic  profde  containing 
BSAG and exosomes labeled for MHC class 
1I. Bars, 0.1 ~m. 
analyzed by SDS-PAGE (Fig. 5  B). After pulse labeling, the 
precursor form of the Tfl~ was detected. Complex glycosy- 
lated 3SS-Tfl~,  migrating at  a  slightly lower mobility, was 
detected  after  chasing  the  cells.  In  contrast  to  3SS-MHC 
class  II,  no  3SS-Tt~  was  found  in  the  exosome  fraction, 
even after 24 h  of chase, again illustrating the selective in- 
corporation of MHC  class II in exosomes. 
Exosomes Can Stimulate T  Cells.  The  recovery of SDS- 
stable  MHC  class  II  molecules  from  exosomes  suggested 
their  association with  peptides  (41,  42).  Thus  exosomes 
may be able to present antigens to T  cells. We  tested this 
possibility using antigen presentation assays.  HLA-DR15- 
positive ILN cells and exosomes isolated from culture me- 
dia  of RN  cells  were  allowed  to  bind  peptide  418-427 
from the model antigen HSP 65 of M.  leprae. The cells and 
exosome preparations were then added to the T  cell clone 
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2F10, which recognizes this peptide in the context of HLA- 
DR15  (28,  29).  In  a  parallel experiment,  RN  cells were 
allowed to endocytose the intact HSP 65 protein continu- 
ously for 24 h, washed, and incubated in the absence of an- 
tigen for another  24  h.  Cells and  exosornes isolated from 
the chase medium were then used to stimulate 2F10 cells as 
above.  Both  cells and  exosomes incubated with  antigenic 
peptide (Fig. 6, A  and  C)  and cells and exosomes derived 
from  media  of cells that  were  preincubated with  antigen 
(Fig. 6, B and D) were able to induce specific T  cell responses. 
As a  control, exosomes were prepared from culture media 
of an  equivalent  number  of DP,  A5-negative JY  cells that 
had been incubated either in the presence or absence of the 
antigen.  Although JY  cells secreted an  equivalent amount 
of exosomes,  these were ineffective in stimulating 2F10 T 
cell proliferation (not shown).  For exosomes derived from Figure  3.  Analysis  of  exosomes 
isolated from P,.N cell culture media. 
(A)  Membranes obtained by  differ- 
ential  centrifugation  of cell  culture 
media  were  analyzed  for  the  pres- 
ence  of MHC  class  1I  by  Western 
blotting. Cells were pelleted in two 
sequential centrifugation steps at 300 g 
(lane 1, first run; lane 2, second nan); 
lane  1 contains material from 0.6  ￿ 
106 cells.  Membranes in the culture 
medium  from  20-50  ￿  10 ~'  cells 
were  pelleted  by  sequential  cen- 
trifuguation  steps:  twice  at  1,200 g 
(lanes 3 and 4) and once at 10,000g 
(lane  5),  70,000  g  (lane  6),  and 
100,000 g  (lane  7). The pellets were 
solubilized at  100~  under reducing 
conditions  and  analyzed  by  SDS- 
PAGE.  Per-lane samples equivalent 
tO  106  cells were loaded.  Class  II  c~ 
and 13 chains were recovered mainly 
from the cells  (lane  1) and from the 
70,O00-g  pellet (lane  6).  (/3) Mem- 
branes  pelleted from  culture  media 
at  70,000  g  were  fractionated  by 
floatation  on  sucrose  gradients. 
MHC class II from gradient fractions 
was solubilized at room temperature 
at  nonreducing  conditions  and  de- 
tected by Western blotting. Class  1I 
molecules  were  recovered  in  frac- 
uons  5-12  corresponding to  densi- 
ties of 1.22-1.08 g/ml. The majority 
of MHC class II was in the SDS-sta- 
ble compact form with a molecular 
mass  of ~"56-60  kD  (Cot/[~).  (C) 
Whole-mount  electron  microscopy 
of the  70,000-g  pellet  imnmnogold 
labeled for MHC class 1I. The pellet 
is  composed  of 60-80-nm  vesicles 
showing abundant MHC  class I1 la- 
beling at their surface. Bar, 0.2 ~m. 
RN  cells  that  had been  preincubated  with  antigen,  a  half- 
maximal  T  cell  response  was  obtained  with  an  amount  of 
exosomes  secreted by 3  X  10 s  cells in 24  h  (Fig.  6  D).  For 
P-,N cells that had been  preincubated  with  antigen,  2  ￿  104 
cells  were  required  to  achieve  the  half-maximal  T  cell  re- 
sponse  (Fig.  6  B).  To  test whether  these responses were  as- 
sociated  with  MHC  class  II,  exosomes  to  which  peptide 
had  been  added  were  incubated  in  the  presence  of mAbs 
1166  B  Lymphocytes Secrete Antigen-presenting Vesicles Figure 4.  Differential  protein  composition  of 
exosomes and plasma membranes.  (A) Exosomes 
contain  compact  MHC  class  II  but  lack  TfR.. 
Samples corresponding to 3  ￿  106  cells were ap- 
plied in lanes  1 and 3,  Samples corresponding to 
exosome  preparations  from  the  media  of  15  ￿ 
106 cells were apphed in lanes 2  and  4.  The left 
panel shows Western blot analysis of MHC  class 
II from cells (lane I) and 70,000-g pellets (lane 2). 
The  samples  were  incubated  at  20~  at  nonre- 
ducing conditions  (NB/NR)  before SDS-PAGE. 
Compact  c~/13 timers  (Cot/13)  are  detected  in 
both  the  cell  samples  (lane  1)  and the  70,000-g 
pellet  (lane 2). The fight panel shows a Western 
blot for TfR from cells  (lane 3) and the 70,000-g 
pellet  (lane  4).  A  major  band with  a  molecular 
mass of 180 kD  (Tftk dimer) is present in the cell 
lysate but is absent in the 70,000-g pellet.  (B) Bi- 
otinylated proteins on the plasma membrane and 
on  exosomes.  Cells  (lanes  1 and  3-5)  and  exo- 
somes  (lanes  2  and  6-8)  were  biotinylated  and 
lysed.  Biotinylated  proteins  from  either  total 
lysates  (lanes  1  and  2)  or  immunoprecipitates 
from  the  lysates  (lanes  3-8)  were  assayed  by 
Western  blotting  using  125I-streptavidin.  Clear 
examples  of biotinylated proteins  selectively en- 
riched in either the plasma membrane (lane 1, de- 
rived  from  3  ￿  105  cells)  or  exosomes  (lane  2, 
derived from the medium of 3  ￿  107 cells)  are in- 
dicated by arrowheads.  MHC  class II complexes 
were immunoprecipitated from cell lysates  (lanes 
3-5, 3  ￿  106 cells)  and lysed exosomes (from the 
medium of 3  ￿  107 cells) using either T/i36 (lanes 
3 and 6) or DA6.231  (lanes 4 and 7). In the con- 
trol lanes (5 and 8),  an irrelevant mAb was used. 
The precipitated samples were eluted at 95~  re- 
suiting in the dissociation of the c~ and 13 chains 
(arrows). Biotinylated  proteins  were  detected  on 
Western blots using 125I-streptavidin.  For the de- 
tection of total biotinylated proteins  (lanes  1 and 
2),  the  setting  of  the  Phospholmager  was  six 
times less sensitive compared with the setting for 
the immunoprecipitates.  Molecular mass markers 
(106,  80, 49.5,  and 32.5 kD)  are indicated at the 
fight. 
directed  against  HLA-DR  (B.8.11.2)  or  HLA-DP  (B7.21) 
and  then  added  to  the  T  cells.  Anti-HLA-DR  blocked  T 
cell  prohferation  completely,  whereas  anti-HLA-DP  was 
ineffective  (Fig.  6,  triangles  and  circles,  respectively).  Thus, 
stimulation  of T  cells  by  exosomes  was  DR  restricted.  We 
also tested  whether  exosomes  derived  from  a  routine  B  cell 
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line were  able to  generate  a  T  cell response.  Exosomes  were 
isolated  from  the  culture  medium  of the murine  B  cell line 
(I-E +)  TA3  and  incubated  in  the  presence  or  absence  of a 
RNase-derived  peptide  (aa 90-105).  Exosomes  and cells were 
used  to  stimulate  WA.23  hybridoma  cells  that  specifically 
90-105  peptide-IE  complexes.  Fig.  7  shows  that  recognize  k B ceil hnes secrete exosomes able to specifically stimulate T 
cells. 
Figure  5.  Release of newly synthesized class II molecules, tLN cells 
were pulse labeled with [35S]methionine  for 45 min (lane 0) followed  by a 
chase in the absence of label for 6, 12, or 24 h. (A) MHC class I! mole- 
cules were immunoprecipitated from lysates of the cells and pelleted exo- 
somes, dissociated from the beads at  nonreducing conditions at  room 
temperature, and analyzed by SDS-PAGE and fluorography. MHC class 
II immunoprecipitated as SDS-unstable complexes of cl/13 I chain. SDS- 
stable ~x/13 dimers were recovered from the cells but not from the me- 
dium after 6 h of chase. In the medium, SDS-stable ot/13 dimers are de- 
tected after 12 h of chase, and this signal is considerably  increased at 24 h. 
(/3) The Tfl~ was immunoprecipitated from lysates of the cells and pel- 
leted exosomes. No TfR was detected in the exosomal  fraction after 24 h 
of chase. 
exosomes released by 2  ￿  107 TA3 cells over 24 h  exposed 
to 10 ~M P,  Nase (90-105)  peptide were capable of stimu- 
lating IL-2 secretion by WA.23 cells.  Control culture me- 
dium and the supernatant obtained after ultracentrifugation 
of exosomes did not stimulate  IL-2 secretion.  Lower pep- 
tide  concentrations  (0.1-1  p~M) produced  stimulation  of 
WA.23  ceils  when  presented  by intact  TA3  cells  but  not 
when presented by exosomes (data not shown).  In conclu- 
sion,  our observations show that these human and rnurine 
Discussion 
In this study we show that, in B  ceils,  the bruiting mem- 
brane  of MIICs can fuse with  the plasma membrane in an 
exocytic fashion, resulting in the release of small membrane 
vesicles (exosomes) into the culture media. Exosome release 
as a consequence of  fusion ofmultivesicular bodies with the 
plasma  membrane  has  been  documented  for reticulocytes 
(25,  26).  Although our observations suggest that this  phe- 
nomenon is common to several B  ceil lines, it has not been 
described previously. Biochemical data of more than a de- 
cade ago on so-called shedding of class II molecules by mu- 
rine B  cell lines,  however,  may be related  to the observa- 
tions we describe here.  These studies document the release 
of  intact MHC class II molecules (43) recovered in 100,000-g 
fractions from B  ceil culture media (44). The MHC  class II 
molecules were part of supramolecular particles containing 
membrane hpids  (45).  The release was interpreted  as shed- 
ding of plasma membrane.  Our present observations throw 
new light on these data and suggest that the released MHC 
class  II-containing particles  in fact were  exosomes.  Other 
early  studies  demonstrated  the  presence  of class  II mole- 
cules associated with membrane hpids in serum (46), which 
suggests the existence of exosomes in vivo. However, a pos- 
sible relationship  between  exosomes and  circulating forms 
of MHC class II needs further analysis. 
Our conclusion that MiICs in B  cells  are exocytic com- 
partments  is based  on the  following observations"  (a)  The 
plasma membrane showed indentations reminiscent of fused 
MIICs that contained vesicles similar in size and morphol- 
ogy to those present in intracellular MIICs (Fig. 2).  (b) The 
vesicles present  in MIICs and at the  ceil surface expressed 
the same markers, MHC class II (Fig. 2), LAMP1 (Fig. 2 B), 
and CD63  (not shown).  LAMP1  and CD63 were not de- 
tected at other regions of the plasma membrane.  (c)  Inter- 
nalized tracer particles were reexternalized and appeared in 
the  MIIC  fusion profiles  (Fig.  2).  (d)  Membrane  vesicles 
similar in morphology to exosomes could be isolated from 
the  culture  media  by differential  centrifugation  and  flota- 
tion on sucrose gradients  (Fig.  3  C).  (e) Purified exosomes 
did not contain TilLs,  a  marker for the plasma membrane 
and endosomes (Figs. 4 A  and 5  B).  Furthermore,  the total 
surface protein composition of exosomes differed from that 
of the  plasma  membrane  as  revealed by surface biotinyla- 
tion  (Fig.  4  /3). Together,  these  observations strongly argue 
against the  idea that  MHC  class  II-containing membranes 
in  the  media  resulted  from  plasma  membrane  shedding. 
The  release  of MHC  class  II molecules  from the  ceils via 
exosomes is significant.  When the cells were metabolically 
labeled with  [35S]methionine, within 24 h  10  •  4% of the 
newly synthesized MHC class I! was found in exosomes re- 
covered from the media. 
Cell fractionation studies  from several laboratories  have 
indicated  that  antigen  processing  and  peptide  loading  of 
MHC  class  II molecules  probably occurs in  MIICs or re- 
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Figure 6.  Presentation of HSP 65 antigen by HLA- 
DR15 + R.N B cells and exosomes to the CD4 + T cell 
clone 2F10. Proliferative responses  to naive cells (A),  to 
cells preincubated with antigen (B), to exosomes de- 
rived from naive cells (C), and to exosomes derived 
from  cells preincubated with antigen  (D). The solid 
symbols show proliferation measurements after addi- 
tion of HSP 65-derived peptide (418-427); the open 
symbols show where peptide was not added. HLA class 
II restriction was determined by adding 10 ~g/ml anti- 
DR antibody (triangles),  anti-DP (circles), or no antibody 
(squares).  The exosomes at the  highest concentration 
were derived from media of 1.6 ￿  106 cells. All assays 
were performed in triplicate, and results are expressed 
in cpm [3H]thymidine incorporated into T  cells. The 
SEM for triphcate cpm measurements was <10%. Re- 
sults shown form a representative example of experi- 
ments performed in duplicate. 
lated endocytic compartments (15-19). The pathway(s) via 
which intracellular MHC  class II molecules are transported 
from the MIICs to the cell surface are presently unknown. 
Since the limiting membrane of MIICs contains MHC  class 
II molecules and is incorporated in the plasma membrane 
during exocytic fusion, this pathway may contribute to MHC 
class II transport to the plasma membrane. However fusion 
of MIICs with the plasma membrane is not likely to be the 
only, or even the major, pathway of MHC  class II delivery 
to the cell surface.  First, our metabolic labeling data show 
that the release of newly synthesized MHC  class II into the 
medium  (Fig.  5  A)  occurred  with  kinetics  much  slower 
than  transport  of newly synthesized MHC  class II  mole- 
cules from MIIC to the plasma membrane (3, 41). A  possi- 
ble caveat of this interpretation is that sticking of released 
exosomes to  the plasma membrane  may slow down  their 
recovery from the medium. Second, we found that predom- 
inantly multivesicular MIICs fused with the plasma mem- 
brane, whereas electron microscopic and cell fractionation 
data (16)  suggest that significant amounts  of MHC  class II 
are transported to other types of MIICs. We have identified 
two types ofMIICs: multivescular ones that received endocy- 
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tosed tracer first (early MIICs) and multilaminar MIICs po- 
sitioned later in the  endocytic pathway  (late MIICs).  The 
exocytic profiles,  and  the  70,000-g  pellets obtained from 
the culture media, contained vesicles (exosomes) rather than 
membrane  sheets,  suggesting  that  secretion  is  mainly  re- 
stricted  to  the  multivesicular MIICs.  The  internal  MIIC 
vesicles are formed by inward budding of the limiting mem- 
brane of MIICs (see reference 21,  Figs.  16 and  17)  similar 
to those described for multivesicular bodies in other cell types 
(47). Therefore the exosomes were expected to expose the 
luminal domain of MHC  class II molecules at their surface. 
This orientation was confirmed by immunogold labehng on 
cryosections of exosomes and by immunogold labeling of 
isolated intact exosomes. 
In multivesicular endosomes, which share many features 
with MIICs, internal vesicles contain receptors destined for 
degradation, whereas recycling receptors are sorted to  the 
limiting membrane  (40, 48). MIICs in APC may represent 
a similar type of sorting device to spatially segregate MHC 
class II molecules to  the intemal vesicles, in order to  dis- 
charge them from  the  cells through  exocytosis. Thus,  fu- 
sion of MIICs with the plasma membrane  may allow cells 40000 
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Figure 7.  Peptide presentation by the exosomes isolated from the cul- 
ture medium of the murine B cell line TA3. WA.23 T hybridoma cells 
(10  s cells/well)  were incubated with 10 p,M ribonuclease  (90-105) peptide 
in the presence of intact TA3 cells (10  s cells/well), exosomes (70,000-g 
pe/let), supernatant from the 70,O00-g spin, or normal medium. The wells 
with exosornes contained material isolated from medium containing 2 ￿ 
107 cells. T cell response was determined by IL-2 secretion, measured us- 
ing a CTLL cell proliferation and [3H]methyl thymidine incorporation 
bioassay. Lower concentrations ofpeptide (0.1-1 p,M) produced stimula- 
tion with TA3 cells  but not with exosornes (data not shown). 
to  discard MHC  molecules  via  exosomes.  However,  we 
now document the presence of presentable peptide-MHC 
class II complexes at the surface of exosomes. Peptide gen- 
erated and bound to MHC  class II intracellularly, as well as 
those bound  to MHC  class II on  exosomes in vitro, pro- 
duced a strong, peptide-specific and MHC  class II-restricted 
stimulation  of T  cells.  Exosomes  therefore  fulfill the  re- 
quirements  to  induce  T  cell responses,  including the  ex- 
pression  of ubiquitous  accessory molecules  (49).  Prelimi- 
nary observations have indeed indicated that several of these 
molecules (]37, ICAM, LFA-3) are present in exosome prep- 
arations (our unpublished data). Our study does not provide 
conclusive information about the efficiency of antigen pre- 
sentation by exosomes. From the data presented in Fig. 6, it 
can be estimated that exosomes are ~10-20  times less effi- 
cient in antigen presentation than cells. However, it should 
be  considered  that  in  antigen  presentation  assays,  contact 
between B  and T  cells may be optimized selectively because 
of sedimentation of cells but not of exosomes. 
Secretion of exosomes by B  lymphocytes is reminiscent 
of that of the internal vesicles in cytolytic granules of CTL 
(50,  51). Both MIICs and cytolytic granules are lysosome- 
like compartments. The internal vesicles of cytolytic gran- 
ules are exocytosed by the CTL upon CTL-target cell in- 
teraction, and presumably mediate the killing of target cells 
(50).  Whether  B  cell exosomes  also  have  an  extracellular 
physiological role in vivo remains to be established. It has 
been suggested that follicular dendritic cells are able to pick 
up MHC  class II molecules released by surrounding B  cells 
by an unknown  mechanism (52).  The possibility that exo- 
somes provide for transfer units  of MHC  class II-peptide 
complexes between different cells of the immune system is 
worth studying. Preliminary observations on physiological 
APC like dendritic cells, monocytes, and macrophages, which 
all contain multivesicular MIICs, have  indicated the pres- 
ence of exosomes at their surface. It can be speculated that 
in vivo, in the circulation, exosomes may function as trans- 
port vehicles for MHC  class II-peptide complexes respon- 
sible for maintenance of long-term T  cell memory or T  cell 
tolerance. Further investigations are required to explore the 
usefulness of exosomes, in particular as biological vehicles, 
in immunotherapy. 
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